Intco Medical Technology Co.Ltd(300677) : Announcement on the proposed purchase of directors, supervisors and senior executives liability insurance

Securities code: 300677 securities abbreviation: Intco Medical Technology Co.Ltd(300677) Announcement No.: 2022-014 Intco Medical Technology Co.Ltd(300677)

Announcement on the proposed purchase of directors, supervisors and senior managers’ liability insurance

The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.

Intco Medical Technology Co.Ltd(300677) (hereinafter referred to as “the company”) held the 55th meeting of the second board of directors and the 47th meeting of the second board of supervisors on February 23, 2022, and deliberated and adopted the proposal on the proposed purchase of director supervisor senior liability insurance respectively. In order to further improve the risk management system, promote the directors, supervisors and senior managers of the company to fully perform their duties, reduce the operational risks of the company and protect the interests of investors, the company plans to purchase liability insurance for the company and all directors, supervisors and senior managers in accordance with the relevant provisions of the standards for the governance of listed companies. According to the articles of association and relevant laws and regulations, all directors and supervisors of the company abstain from voting, and this proposal needs to be submitted to the general meeting of shareholders of the company for deliberation and approval.

Relevant matters are hereby announced as follows:

1、 Liability insurance scheme

1. Applicant: Intco Medical Technology Co.Ltd(300677)

2. Insured: the company and its directors, supervisors and senior managers

3. Compensation limit: no more than RMB 80 million / year (the specific amount shall be subject to the amount determined through negotiation with the insurance company)

4. Premium expenditure: no more than 400000 yuan / year (finally determined according to the quotation and negotiation of the insurance company)

5. Insurance period: 12 months (it can be renewed or re insured every year)

In order to improve the efficiency of decision-making, the board of directors requested the general meeting of shareholders to authorize the management of the company to handle the affairs of all directors Matters related to the purchase of liability insurance for supervisors and senior managers (including but not limited to determining other relevant responsible personnel; determining insurance companies; determining insurance amount, premium and other insurance terms; selecting and appointing insurance brokerage companies or other intermediaries; signing relevant legal documents and dealing with other matters related to insurance), And handle renewal or re insurance and other related matters on the premise of not exceeding the above amount.

According to the articles of association and relevant laws and regulations, all directors and supervisors of the company avoided voting on this matter. The purchase of liability insurance for the company and all directors, supervisors and senior managers will be directly submitted to the general meeting of shareholders of the company for deliberation.

2、 Opinions of independent directors

After review, the independent directors believe that the company’s plan to purchase liability insurance for directors, supervisors and senior managers is conducive to improving the company’s risk control system, protecting the rights and interests of the company and its directors, supervisors and senior managers, promoting the relevant responsible personnel to fully exercise their rights and perform their duties, promoting the healthy development of the company, and there is no situation damaging the interests of the company and all shareholders, The deliberation procedure is legal and compliant, so it is agreed to submit the proposal directly to the first extraordinary general meeting of shareholders in 2022 for deliberation.

3、 Opinions of the board of supervisors

The board of supervisors believes that the company’s purchase of directors, supervisors and senior managers’ liability insurance is conducive to improving the risk control system, protecting the rights and interests of the company and its directors, supervisors and senior managers, and promoting relevant responsible personnel to fully exercise their supervision rights and perform relevant duties. The deliberation procedures for the purchase of directors, supervisors and senior managers’ liability insurance are legal and compliant, and there is no damage to the interests of the company and all shareholders.

4、 Documents for future reference

1. Resolutions of the 55th meeting of the second board of directors of the company;

2. Resolutions of the 47th meeting of the second board of supervisors of the company;

3. Independent opinions of independent directors on matters related to the 55th meeting of the second board of directors.

It is hereby announced.

Intco Medical Technology Co.Ltd(300677) board of directors

February 23, 2022

- Advertisment -